Are All Stent Bearers Equal? Ureteral Stent Symptoms in Kidney Transplant Patients: A Case-Control Prospective Study

The aim of this study is to conduct a prospective, controlled single-center study to determine the prevalence and types of ureteral stent symptoms in kidney transplant (KTx) recipients and compare them with nontransplant subjects. From December 2012 to June 2019, a total of 102 patients having under...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of endourology Vol. 36; no. 3; p. 410
Main Authors:	Orozco Murillo, Héctor M, Montaño Roca, Benjamín, Kobashi Sandoval, Elisa, Varela Prieto, Jesús, Arzate Soriano, Rocío Estephanía, Rodriguez Domínguez, Jorge, Terrazas Cervantes, Miguel A, Campos Negrete, Aaron, Canto Castillo, Jose M, Gebhardt, Denisse, Pliego Zermeño, Javier A, Martinez Estaban, Alejandro, Mendez-Probst, Carlos E
Format:	Journal Article
Language:	English
Published:	United States 01-03-2022
Subjects:	Female Humans Kidney Transplantation - adverse effects Male Pain - etiology Prospective Studies Stents - adverse effects Surveys and Questionnaires Ureter - surgery Urolithiasis urolithiasis USSQ utereroscopy stents renal transplant
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The aim of this study is to conduct a prospective, controlled single-center study to determine the prevalence and types of ureteral stent symptoms in kidney transplant (KTx) recipients and compare them with nontransplant subjects. From December 2012 to June 2019, a total of 102 patients having undergone a KTx and Double-J stent (DJS) placement and 88 patients having undergone endourological lithotripsy and DJS placement were enrolled. The Ureteral Stent Symptom Questionnaire (USSQ) was administered to patients with a median of 25 (KTx) and 31 (urolithiasis) days after stent placement. USSQ scores were used to compare symptoms between the two groups. Of the 190 patients enrolled, 88 belonged to the lithotripsy group (control group) and 102 to the KTx recipients' group. Mean score for urinary symptoms was 21.42 for KTx patients 27.53 for control patients with statistical significance ( < 0.001, CI -7.792 to -4.433). The visual analog scale, overall bother, pain at voiding, flank pain at voiding, and frequency of painkiller use scores were significantly higher for control patients than for KTx patients ( = 0.024, <0.001, <0.001, <0.001, and 0.014, respectively). Frequency of rest, changes in work duration, work domain score, suspicion of urinary tract infection (UTI), and need for professional assistance scores were significantly lower for KTx patients than the control. There were no significant differences in general health and sexual domains between groups. KTx recipients have significantly fewer urinary symptoms, pain, work-related disturbances, suspected UTIs, and hospitalizations associated with stent placement than urolithiasis patients.
ISSN:	1557-900X
DOI:	10.1089/end.2021.0570